Colon microbiota fermentation of dietary prebiotics towards short-chain fatty acids and their roles as anti-inflammatory and antitumour agents: A review

Journal of Functional Foods

Volumn 25, Issue , 2016, Pages 511-522

  Fernández, Javier ^a   Redondo Blanco, Saúl ^a   Gutiérrez del Río, Ignacio ^a   Miguélez, Elisa M ^a   Villar, Claudio J ^a   Lombó, Felipe ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Butyrate; Colorectal cancer; Gut microbiota; Prebiotic food; Propionate; Short chain fatty acid

Indexed keywords

EID: 84978531650     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.06.032     Document Type: Review

References (104)

1. Aminov R.I., Walker A.W., Duncan S.H., Harmsen H.J.M., Welling G.W., Flint H.J. Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Applied and Environmental Microbiology 2006, 72(9):6371-6376. http://doi.org/10.1128/AEM.00701-06.
2. Barcenilla A., Pryde S.E., Martin J.C., Duncan S.H., Stewart C.S., Henderson C., Flint H.J. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Applied and Environmental Microbiology 2000, 66(4):1654-1661. Retrieved from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=92037%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
3. Barile D., Rastall R.A. Human milk and related oligosaccharides as prebiotics. Current Opinion in Biotechnology 2013, 24(2):214-219. http://doi.org/10.1016/j.copbio.2013.01.008.
4. Barker H.A., Kahn J.M., Hedrick L. Pathway of lysine degradation in Fusobacterium nucleatum. Journal of Bacteriology 1982, 152(1):201-207. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=221392%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
5. Belenguer A., Duncan S.H., Calder A.G., Holtrop G., Louis P., Lobley G.E., Flint H.J. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Applied and Environmental Microbiology 2006, 72(5):3593-3599. http://doi.org/10.1128/AEM.72.5.3593-3599.2006.
6. Borromei C., Careri M., Cavazza A., Corradini C., Elviri L., Mangia A., Merusi C. Evaluation of fructooligosaccharides and inulins as potentially health benefiting food ingredients by HPAEC-PED and MALDI-TOF MS. International Journal of Analytical Chemistry 2009, 2009:530639. http://doi.org/10.1155/2009/530639.
7. Bosscher D., Breynaert A., Pieters L., Hermans N. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 2009, 60(Suppl. 6):5-11. http://www.ncbi.nlm.nih.gov/pubmed/20224145.
8. Brownawell A.M., Caers W., Gibson G.R., Kendall C.W.C., Lewis K.D., Ringel Y., Slavin J.L. Prebiotics and the health benefits of fiber: Current regulatory status, future research, and goals. The Journal of Nutrition 2012, 124:962-974. http://doi.org/10.3945/jn.112.158147.plant.
9. Bruce W.R., Corpet D.E. The colonic protein fermentation and insulin resistance hypotheses for colon cancer etiology: Experimental tests using precursor lesions. European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP) 1996, 5(Suppl. 2):41-47. http://www.ncbi.nlm.nih.gov/pubmed/9061294.
10. Buckel W., Barker H.A. Two pathways of glutamate fermentation by anaerobic bacteria. Journal of Bacteriology 1974, 117(3):1248-1260. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=246608%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
11. Buckel W., Dorn U., Semmler R. Glutaconate CoA-transferase from Acidaminococcus fermentans. European Journal of Biochemistry / FEBS 1981, 118(2):315-321. http://www.ncbi.nlm.nih.gov/pubmed/6945182.
12. Bustan A., Avni A., Lavee S., Zipori I., Yeselson Y., Schaffer A.A., Riov J., Dag A. Role of carbohydrate reserves in yield production of intensively cultivated oil olive (Olea europaea L.) trees. Tree Physiology 2011, 31(5):519-530. http://doi.org/10.1093/treephys/tpr036.
13. Cairns A.J. Fructan biosynthesis in transgenic plants. Journal of Experimental Botany 2003, 54(382):549-567. http://www.ncbi.nlm.nih.gov/pubmed/12508066.
14. Campos-Vega R., Guevara-Gonzalez R.G., Guevara-Olvera B.L., Dave Oomah B., Loarca-Piña G. Bean (Phaseolus vulgaris L.) polysaccharides modulate gene expression in human colon cancer cells (HT-29). Food Research International 2010, 43(4):1057-1064. http://doi.org/10.1016/j.foodres.2010.01.017.
15. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D.M., Muccioli G.G., Delzenne N.M. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58(8):1091-1103. http://doi.org/10.1136/gut.2008.165886.
16. Capitán-Cañadas F., Ocón B., Aranda C.J., Anzola A., Suárez M.D., Zarzuelo A., de Medina F.S., Martínez-Augustin O. Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice. European Journal of Nutrition 2015, 58(8):1091-1103. http://doi.org/10.1007/s00394-015-0962-6.
17. Chi Z.-M., Zhang T., Cao T.-S., Liu X.-Y., Cui W., Zhao C.-H. Biotechnological potential of inulin for bioprocesses. Bioresource Technology 2011, 102(6):4295-4303. http://doi.org/10.1016/j.biortech.2010.12.086.
18. Conlon M.A., Kerr C.A., McSweeney C.S., Dunne R.A., Shaw J.M., Kang S., Bird A.R., Morell M.K., Lockett T.J., Molloy P.L., Regina A., Toden S., Clarke J.M., Topping D.L. Resistant starches protect against colonic DNA damage and alter microbiota and gene expression in rats fed a Western diet. The Journal of Nutrition 2012, 142(5):832-840. http://doi.org/10.3945/jn.111.147660.
19. Cruz-Bravo R.K., Guevara-González R.G., Ramos-Gómez M., Oomah B.D., Wiersma P., Campos-Vega R., Loarca-Piña G. The fermented non-digestible fraction of common bean (Phaseolus vulgaris L.) triggers cell cycle arrest and apoptosis in human colon adenocarcinoma cells. Genes & Nutrition 2014, 9(1):359. http://doi.org/10.1007/s12263-013-0359-1.
20. Daddaoua A., Martínez-Plata E., López-Posadas R., Vieites J.M., González M., Requena P., Zarzuelo A., Suárez M.D., de Medina F.S., Martínez-Augustin O. Active hexose correlated compound acts as a prebiotic and is antiinflammatory in rats with hapten-induced colitis. The Journal of Nutrition 2007, 137(5):1222-1228.
21. Dewulf E.M., Cani P.D., Claus S.P., Fuentes S., Puylaert P.G.B., Neyrinck A.M., Bindels L.B., de Vos W.M., Gibson G.R., Thissen J.P., Delzenne N.M. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013, 62(8):1112-1121. http://doi.org/10.1136/gutjnl-2012-303304.
22. Duncan S.H., Aminov R.I., Scott K.P., Louis P., Stanton T.B., Flint H.J. Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. International Journal of Systematic and Evolutionary Microbiology 2006, 56(Pt. 10):2437-2441. http://doi.org/10.1099/ijs.0.64098-0.
23. Duncan S.H., Flint H.J. Proposal of a neotype strain (A1-86) for Eubacterium rectale. Request for an opinion. International Journal of Systematic and Evolutionary Microbiology 2008, 58(Pt. 7):1735-1736. http://doi.org/10.1099/ijs.0.2008/004580-0.
24. Duncan S.H., Hold G.L., Harmsen H.J.M., Stewart C.S., Flint H.J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology 2002, 52(Pt. 6):2141-2146. http://doi.org/10.1099/00207713-52-6-2141.
25. Duncan S.H., Holtrop G., Lobley G.E., Calder A.G., Stewart C.S., Flint H.J. Contribution of acetate to butyrate formation by human faecal bacteria. The British Journal of Nutrition 2004, 91(6):915-923. http://doi.org/10.1079/BJN20041150.
26. Eeckhaut V., Van Immerseel F., Croubels S., De Baere S., Haesebrouck F., Ducatelle R., Louis P., Vandamme P. Butyrate production in phylogenetically diverse Firmicutes isolated from the chicken caecum. Microbial Biotechnology 2011, 4(4):503-512. http://doi.org/10.1111/j.1751-7915.2010.00244.x.
27. El-Semman I.E., Karlsson F.H., Shoaie S., Nookaew I., Soliman T.H., Nielsen J. Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction. BMC Systems Biology 2014, 8:41. http://doi.org/10.1186/1752-0509-8-41.
28. Elleuch M., Bedigian D., Roiseux O., Besbes S., Blecker C., Attia H. Dietary fibre and fibre-rich by-products of food processing: Characterisation, technological functionality and commercial applications: A review. Food Chemistry 2011, 124(2):411-421. http://doi.org/10.1016/j.foodchem.2010.06.077.
29. Escobedo G., López-Ortiz E., Torres-Castro I. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance. Revista de Investigación Clínica; Organo Del Hospital de Enfermedades de La Nutrición 2015, 66(5):450-459.
30. FAO/WHO Codex committee on nutrition and foods for special dietary uses. Journal of Chemical Information and Modeling 2008, 53:1-4. http://doi.org/10.1017/CBO9781107415324.004.
31. Fernández J., Redondo-Blanco S., Miguélez E.M., Villar C.J., Clemente A., Lombó F. Healthy effects of prebiotics and their metabolites against intestinal diseases and colorectal cancer. AIMS Microbiology 2015, 1:48-71. http://doi.org/10.3934/microbiol.2015.1.48.
32. Franck A. Technological functionality of inulin and oligofructose. The British Journal of Nutrition 2002, 87(Suppl. 2):S287-S291. http://doi.org/10.1079/BJNBJN/2002550.
33. FUFOSE Scientific concepts of functional foods in Europe. Consensus document. The British Journal of Nutrition 1999, 81(Suppl. 1):S1-S27. http://doi.org/10.1079/BJN19990003.
34. Gallardo K., Thompson R., Burstin J. Reserve accumulation in legume seeds. Comptes Rendus Biologies 2008, 331(10):755-762. http://doi.org/10.1016/j.crvi.2008.07.017.
35. Gerhardt A., Cinkaya I., Linder D., Huisman G., Buckel W. Fermentation of 4-aminobutyrate by Clostridium aminobutyricum: Cloning of two genes involved in the formation and dehydration of 4-hydroxybutyryl-CoA. Archives of Microbiology 2000, 174(3):189-199. http://www.ncbi.nlm.nih.gov/pubmed/11041350.
36. Ghouri Y., Richards D., Rahimi E., Krill J., Jelinek K., DuPont A. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clinical and Experimental Gastroenterology 2014, 7:473-487. http://doi.org/10.2147/CEG.S27530.
37. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. The Journal of Nutrition 1995, 125(6):1401-1412. http://www.ncbi.nlm.nih.gov/pubmed/7782892.
38. Gibson G.R., Scott K.P., Rastall R.A., Tuohy K.M., Hotchkiss A., Dubert-Ferrandon A., Gareau M., Murphy E.F., Saulnier D., Loh G., Macfarlane S., Delzenne N., Ringel Y., Kozianowski G., Dickmann R., Lenoir-Wijnkoop I., Walker C., Buddington R. Dietary prebiotics: Current status and new definition. Food Science and Technology Bulletin: Functional Foods 2010, 7:1-19. http://doi.org/10.1616/1476-2137.15880.
39. Grigelmo-Miguel N., Carreras-Boladeras E., Martín-Belloso O. Development of high-fruit-dietary-fibre muffins. European Food Research and Technology 1999, 210(2):123-128. http://doi.org/10.1007/s002170050547.
40. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.-J. Review article: The role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics 2008, 27(2):104-119. http://doi.org/10.1111/j.1365-2036.2007.03562.x.
41. Hedin C., Whelan K., Lindsay J.O. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: A review of clinical trials. The Proceedings of the Nutrition Society 2007, 66(3):307-315. http://doi.org/10.1017/S0029665107005563.
42. Heerdt B.G., Houston M.A., Augenlicht L.H. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth (&) Differentiation: The Molecular Biology Journal of the American Association for Cancer Research 1997, 8(5):523-532. http://www.ncbi.nlm.nih.gov/pubmed/9149903.
43. Hester C.M., Jala V.R., Langille M.G., Umar S., Greiner K.A., Haribabu B. Fecal microbes, short chain fatty acids, and colorectal cancer across racial/ethnic groups. World Journal of Gastroenterology 2015, 21(9):2759-2769. http://doi.org/10.3748/wjg.v21.i9.2759.
44. Hold G.L., Schwiertz A., Aminov R.I., Blaut M., Flint H.J. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Applied and Environmental Microbiology 2003, 69(7):4320-4324. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=165216%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
45. Høverstad T., Midtvedt T. Short-chain fatty acids in germfree mice and rats. The Journal of Nutrition 1986, 116(9):1772-1776. http://www.ncbi.nlm.nih.gov/pubmed/3761032.
46. Hudcovic T., Kolinska J., Klepetar J., Stepankova R., Rezanka T., Srutkova D., Schwarzer M., Erban V., Du Z., Wells J.M., Hrncir T., Tlaskalova-Hogenova H., Kozakova H. Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: Differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice. Clinical and Experimental Immunology 2012, 167(2):356-365. 10.1111/j.1365-2249.2011.04498.x.
47. Humphries A., Wright N.A. Colonic crypt organization and tumourigenesis. Nature Reviews. Cancer 2008, 8(6):415-424. http://doi.org/10.1038/nrc2392.
48. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011, 61(2):69-90. http://doi.org/10.3322/caac.20107.
49. Karimi R., Azizi M.H., Ghasemlou M., Vaziri M. Application of inulin in cheese as prebiotic, fat replacer and texturizer: A review. Carbohydrate Polymers 2015, 119:85-100. http://doi.org/10.1016/j.carbpol.2014.11.029.
50. Kim Y.S., Milner J.A. Dietary modulation of colon cancer risk. The Journal of Nutrition 2007, 137(Suppl. 11):2576S-2579S. http://www.ncbi.nlm.nih.gov/pubmed/17951506.
51. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87(2):159-170. http://www.ncbi.nlm.nih.gov/pubmed/8861899.
52. Kverka M., Tlaskalova-Hogenova H. Two faces of microbiota in inflammatory and autoimmune diseases: Triggers and drugs. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 2013, 121(5):403-421. Epub 2012 Oct 24. 10.1111/apm.12007.
53. Le Leu R.K., Winter J.M., Christophersen C.T., Young G.P., Humphreys K.J., Hu Y., Gratz S.W., Miller R.B., Topping D.L., Bird A.R., Conlon M.A. Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: A randomised clinical trial. The British Journal of Nutrition 2015, 114(2):220-230. http://doi.org/10.1017/S0007114515001750.
54. Lebesi D.M., Tzia C. Effect of the addition of different dietary fiber and edible cereal bran sources on the baking and sensory characteristics of cupcakes. Food and Bioprocess Technology 2009, 4(5):710-722. http://doi.org/10.1007/s11947-009-0181-3.
55. Leenen C.H.M., Dieleman L.A. Inulin and oligofructose in chronic inflammatory bowel disease. The Journal of Nutrition 2007, 137(Suppl. 11):2572S-2575S. http://doi.org/137/11/2572S.
56. Li M., Bauer L.L., Chen X., Wang M., Kuhlenschmidt T.B., Kuhlenschmidt M.S., Fahey G.C., Donovan S.M. Microbial composition and in vitro fermentation patterns of human milk oligosaccharides and prebiotics differ between formula-fed and sow-reared piglets. The Journal of Nutrition 2012, 142(4):681-689. http://doi.org/10.3945/jn.111.154427.
57. Louis P., Duncan S.H., McCrae S.I., Millar J., Jackson M.S., Flint H.J. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. Journal of Bacteriology 2004, 186(7):2099-2106. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=374397%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
58. Louis P., Flint H.J. Development of a semiquantitative degenerate real-time PCR-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Applied and Environmental Microbiology 2007, 73(6):2009-2012. http://doi.org/10.1128/AEM.02561-06.
59. Louis P., Flint H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters 2009, 294(1):1-8. http://doi.org/10.1111/j.1574-6968.2009.01514.x.
60. Louis P., Hold G.L., Flint H.J. The gut microbiota, bacterial metabolites and colorectal cancer. Nature Reviews. Microbiology 2014, 12(10):661-672. http://doi.org/10.1038/nrmicro3344.
61. Louis P., Young P., Holtrop G., Flint H.J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environmental Microbiology 2010, 12(2):304-314. http://doi.org/10.1111/j.1462-2920.2009.02066.x.
62. Mahowald M.A., Rey F.E., Seedorf H., Turnbaugh P.J., Fulton R.S., Wollam A., Shah N., Wang C., Magrini V., Wilson R.K., Cantarel B.L., Coutinho P.M., Henrissat B., Crock L.W., Russell A., Verberkmoes N.C., Hettich R.L., Gordon J.I. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(14):5859-5864. http://doi.org/10.1073/pnas.0901529106.
63. Martirosyan D.M., Singh J. A new definition of functional food by FFC: What makes a new definition unique?. Functional Foods in Health and Disease 2015, 5(6):209-223.
64. Meyer D. Health benefits of prebiotic fibers. Advances in Food and Nutrition Research 2015, 74:47-91. http://doi.org/10.1016/bs.afnr.2014.11.002.
65. Min Y.W., Park S.U., Jang Y.S., Kim Y.-H., Rhee P.-L., Ko S.H., Joo N., Kim S.I., Kim C.H., Chang D.K. Effect of composite yogurt enriched with acacia fiber and Bifidobacterium lactis. World Journal of Gastroenterology 2012, 18(33):4563-4569. http://doi.org/10.3748/wjg.v18.i33.4563.
66. Ohama H., Ikeda H., Moriyama H. Health foods and foods with health claims in Japan. Toxicology 2006, 221(1):95-111. http://doi.org/10.1016/j.tox.2006.01.015.
67. Orel R., Kamhi Trop T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World Journal of Gastroenterology 2014, 20(33):11505-11524. http://doi.org/10.3748/wjg.v20.i33.11505.
68. Padilla B., Frau F., Ruiz-Matute A.I., Montilla A., Belloch C., Manzanares P., Corzo N. Production of lactulose oligosaccharides by isomerisation of transgalactosylated cheese whey permeate obtained by β-galactosidases from dairy Kluyveromyces. The Journal of Dairy Research 2015, 82(3):356-364. http://doi.org/10.1017/S0022029915000217.
69. Padma Ishwarya S., Prabhasankar P. Prebiotics: Application in bakery and pasta products. Critical Reviews in Food Science and Nutrition 2014, 54(4):511-522. http://doi.org/10.1080/10408398.2011.590244.
70. Paik S.S., Jang K.-S., Song Y.S., Jang S.-H., Min K.-W., Han H.X., Na W., Lee K.H., Choi D., Jang S.J. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumour progression and aggressive phenotype. Annals of Surgical Oncology 2007, 14(12):3453-3459. http://doi.org/10.1245/s10434-007-9541-2.
71. Prosky L., Hoebregs H. Methods to determine food inulin and oligofructose. The Journal of Nutrition 1999, 129(Suppl. 7):1418S-1423S. http://www.ncbi.nlm.nih.gov/pubmed/10395610.
72. Quirós-Sauceda A.E., Palafox-Carlos H., Sáyago-Ayerdi S.G., Ayala-Zavala J.F., Bello-Perez L.A., Alvarez-Parrilla E., de la Rosa L.A., González-Córdova A.F., González-Aguilar G.A. Dietary fiber and phenolic compounds as functional ingredients: Interaction and possible effect after ingestion. Food & Function 2014, 5(6):1063-1072. http://doi.org/10.1039/c4fo00073k.
73. Reichardt N., Duncan S.H., Young P., Belenguer A., McWilliam Leitch C., Scott K.P., Flint H.J., Louis P. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. The ISME Journal 2014, 8(6):1323-1335. http://doi.org/10.1038/ismej.2014.14.
74. Reyes-Pérez F., Salazar-García M.G., Romero-Baranzini A.L., Islas-Rubio A.R., Ramírez-Wong B. Estimated glycemic index and dietary fiber content of cookies elaborated with extruded wheat bran. Plant Foods for Human Nutrition (Dordrecht, Netherlands) 2013, 68(1):52-56. http://doi.org/10.1007/s11130-013-0338-0.
75. Roberfroid M.B. Inulin-type fructans: Functional food ingredients. The Journal of Nutrition 2007, 137(Suppl. 11):2493S-2502S. http://www.ncbi.nlm.nih.gov/pubmed/17951492.
76. Roberfroid M., Gibson G.R., Hoyles L., McCartney A.L., Rastall R., Rowland I., Wolvers D., Watzl B., Szajewska H., Stahl B., Guarner F., Respondek F., Whelan K., Coxam V., Davicco M.J., Léotoing L., Wittrant Y., Delzenne N.M., Cani P.D., Neyrinck A.M., Meheust A. Prebiotic effects: Metabolic and health benefits. The British Journal of Nutrition 2010, 104(Suppl.):S1-S63. http://doi.org/10.1017/S0007114510003363.
77. Roller M., Pietro Femia A., Caderni G., Rechkemmer G., Watzl B. Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. The British Journal of Nutrition 2004, 92(6):931-938. http://www.ncbi.nlm.nih.gov/pubmed/15613255.
78. Ruemmele F.M., Schwartz S., Seidman E.G., Dionne S., Levy E., Lentze M.J. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 2003, 52(1):94-100. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1773532%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
79. Ruiz-Moyano S., Totten S.M., Garrido D.A., Smilowitz J.T., German J.B., Lebrilla C.B., Mills D.A. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Applied and Environmental Microbiology 2013, 79(19):6040-6049. http://doi.org/10.1128/AEM.01843-13.
80. Rumessen J.J., Bodé S., Hamberg O., Gudmand-Høyer E. Fructans of Jerusalem artichokes: Intestinal transport, absorption, fermentation, and influence on blood glucose, insulin, and C-peptide responses in healthy subjects. The American Journal of Clinical Nutrition 1990, 52(4):675-681. http://www.ncbi.nlm.nih.gov/pubmed/2206038.
81. Sangwan V., Tomar S.K., Ali B., Singh R.R.B., Singh A.K. Production of β-galactosidase from streptococcus thermophilus for galactooligosaccharides synthesis. Journal of Food Science and Technology 2015, 52(7):4206-4215. http://doi.org/10.1007/s13197-014-1486-4.
82. Sangwan V., Tomar S.K., Singh R.R.B., Singh A.K., Ali B. Galactooligosaccharides: Novel components of designer foods. Journal of Food Science 2011, 76(4):R103-R111. http://doi.org/10.1111/j.1750-3841.2011.02131.x.
83. Sarao L.K., M A. Probiotics, prebiotics and microencapsulation - A review. Critical Reviews in Food Science and Nutrition 2015, http://doi.org/10.1080/10408398.2014.887055.
84. Scharlau D., Borowicki A., Habermann N., Hofmann T., Klenow S., Miene C., Munjal U., Stein K., Glei M. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutation Research 2009, 682(1):39-53. http://doi.org/10.1016/j.mrrev.2009.04.001.
85. Schwiertz A., Le Blay G., Blaut M. Quantification of different Eubacterium spp. in human fecal samples with species-specific 16S rRNA-targeted oligonucleotide probes. Applied and Environmental Microbiology 2000, 66(1):375-382. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=91833%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
86. Scott K.P., Martin J.C., Campbell G., Mayer C.-D., Flint H.J. Whole-genome transcription profiling reveals genes up-regulated by growth on fucose in the human gut bacterium "Roseburia inulinivorans". Journal of Bacteriology 2006, 188(12):4340-4349. http://doi.org/10.1128/JB.00137-06.
87. Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., Rennick D.M., Sartor R.B. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infection and Immunity 1998, 66(11):5224-5231.
88. Slavin J.L. Position of the American Dietetic Association: Health implications of dietary fiber. Journal of the American Dietetic Association 2008, 108(10):1716-1731. http://www.ncbi.nlm.nih.gov/pubmed/18953766.
89. Stein K., Borowicki A., Scharlau D., Schettler A., Scheu K., Obst U., Glei M. Effects of synbiotic fermentation products on primary chemoprevention in human colon cells. The Journal of Nutritional Biochemistry 2012, 23(7):777-784. http://doi.org/10.1016/j.jnutbio.2011.03.022.
90. Tlaskalova-Hogenová H.1., Stěpánková R., Kozáková H., Hudcovic T., Vannucci L., Tučková L., Rossmann P., Hrnčíř T., Kverka M., Zákostelská Z., Klimešová K., Přibylová J., Bártová J., Sanchez D., Fundová P., Borovská D., Srůtková D., Zídek Z., Schwarzer M., Drastich P., Funda D.P. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: Contribution of germ-free and gnotobiotic animal models of human diseases. Cellular and Molecular Immunology 2011, 8(2):110-120. 10.1038/cmi.2010.67.
91. Verghese M., Walker L.T., Shackelford L., Chawan C.B. Inhibitory effects of nondigestible carbohydrates of different chain lengths on azoxymethane-induced aberrant crypt foci in Fisher 344 rats. Nutrition Research 2005, 25(9):859-868. http://doi.org/10.1016/j.nutres.2005.09.007.
92. Vijn I., Smeekens S. Fructan: More than a reserve carbohydrate?. Plant Physiology 1999, 120(2):351-360. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1539216%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
93. Villanueva-Millán M.J., Pérez-Matute P., Oteo J.A. Gut microbiota: A key player in health and disease. A review focused on obesity. Journal of Physiology and Biochemistry 2015, 2015:509-525. http://doi.org/10.1007/s13105-015-0390-3.
94. Vital M., Howe A.C., Tiedje J.M. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. mBio 2014, 5(2):e00889. http://doi.org/10.1128/mBio.00889-14.
95. Vital M., Penton C.R., Wang Q., Young V.B., Antonopoulos D.A., Sogin M.L., Morrison H.G., Raffals L., Chang E.B., Huffnagle G.B., Schmidt T.M., Cole J.R., Tiedje J.M. A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome 2013, 1(1):8. http://doi.org/10.1186/2049-2618-1-8.
96. Waby J.S., Chirakkal H., Yu C., Griffiths G.J., Benson R.S.P., Bingle C.D., Corfe B.M. Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line. Molecular Cancer 2010, 9:275. http://doi.org/10.1186/1476-4598-9-275.
97. Wasilewski A., Zielińska M., Storr M., Fichna J. Beneficial effects of probiotics, prebiotics, synbiotics, and psychobiotics in inflammatory bowel disease. Inflammatory Bowel Diseases 2015, 1-9. http://doi.org/10.1097/MIB.0000000000000364.
98. West C.E., Renz H., Jenmalm M.C., Kozyrskyj A.L., Allen K.J., Vuillermin P., Prescott S.L. The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies. The Journal of Allergy and Clinical Immunology 2015, 135(1):3-13. in-FLAME Microbiome Interest Group, quiz 14. http://doi.org/10.1016/j.jaci.2014.11.012.
99. Westenbrink S., Brunt K., van der Kamp J.-W. Dietary fibre: Challenges in production and use of food composition data. Food Chemistry 2012, 140(3):562-567. http://doi.org/10.1016/j.foodchem.2012.09.029.
100. Westermann P., Ahring B.K., Mah R.A. Acetate production by methanogenic bacteria. Applied and Environmental Microbiology 1989, 55(9):2257-2261. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=203065%7B&%7Dtool=pmcentrez%7B&%7Drendertype=abstract.
101. Wilson A.J., Chueh A.C., Tögel L., Corner G.A., Ahmed N., Goel S., Byun D.S., Nasser S., Houston M.A., Jhawer M., Smartt H.J., Murray L.B., Nicholas C., Heerdt B.G., Arango D., Augenlicht L.H., Mariadason J.M. Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Research 2010, 70(2):609-620. http://doi.org/10.1158/0008-5472.CAN-09-2327.
102. Winter J., Nyskohus L., Young G.P., Hu Y., Conlon M.A., Bird A.R., Topping D.L., Le Leu R.K. Inhibition by resistant starch of red meat-induced promutagenic adducts in mouse colon. Cancer Prevention Research 2011, 4(11):1920-1928. http://doi.org/10.1158/1940-6207.CAPR-11-0176.
103. Wong J.M.W., de Souza R., Kendall C.W.C., Emam A., Jenkins D.J.A. Colonic health: Fermentation and short chain fatty acids. Journal of Clinical Gastroenterology 2006, 40(3):235-243. http://www.ncbi.nlm.nih.gov/pubmed/16633129.
104. Zhang J., Wu G., Chapkin R.S., Lupton J.R. Energy metabolism of rat colonocytes changes during the tumourigenic process and is dependent on diet and carcinogen. The Journal of Nutrition 1998, 128(8):1262-1269. http://www.ncbi.nlm.nih.gov/pubmed/9687542.